Institutional investors hold a majority ownership of HRTX through the 107.19% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2017, these large investors purchased a net $5.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TANG CAPITAL MANAGEMENT LLC Bought 58.8 Thousand shares of Heron Therapeutics Inc